Global Pharmaceutical & Biotechnology Outlook 2014: Rising Stars (1) - PowerPoint PPT Presentation

About This Presentation
Title:

Global Pharmaceutical & Biotechnology Outlook 2014: Rising Stars (1)

Description:

Approval of new drugs, successful launches, maturing pipeline sustained the growth trajectory of biotech companies resulting in successful IPOs. We expect the optimism to percolate further into companies with novel technology platforms and targets. For more details on the trend in drug approvals, upcoming milestones and M&A in coming years please see Global Pharmaceutical and Biotechnology Outlook 2014 :Rising Stars – PowerPoint PPT presentation

Number of Views:60
Slides: 8
Provided by: bharatbookseo
Category:

less

Transcript and Presenter's Notes

Title: Global Pharmaceutical & Biotechnology Outlook 2014: Rising Stars (1)


1
Global Pharmaceutical Biotechnology Outlook
2014 Rising Stars
One-Stop Shop for Business Information
2
Summary
Innovations have contributed to the availability
of a range of new treatments for diseases
resulting in improvement in the length and
quality of life and reduced disease burden for
individuals and society.  However, the need for
innovative therapies for unmet needs /challenging
diseases continues to grow, accelerating the pace
of drug development directly or through
partnership/ in-licensing. We expect innovation
and improved drugs therapies through novel target
discovery and technology platforms to continue to
flow from the backyards of small research focused
companies (Rising Stars, RS non-profitable
biotech companies) in coming years.  
3
Approval of new drugs, successful launches,
maturing pipeline sustained the growth trajectory
of biotech companies resulting in successful
IPOs. We expect the optimism to percolate further
into companies with novel technology platforms
and targets. For more details on the trend in
drug approvals, upcoming milestones and MA in
coming years please see Global Pharmaceutical and
Biotechnology Outlook 2014 Rising Stars
4
Table Of Contents
  1. Ablynx- Nanobodies Turnarond on the Horizon!
  2. Ambit Biosciences- Quizartinib in RR-AML
    Delayed but not Dead!
  3. Basilea- Drugs for Bad Bugs Isavuconazole
    Watch out for ACTIVE and VITAL
  4. Cempra (CEMP)
  5. Endocyte-
  6. Enanata- The Party to Continue in 2014 2nd in
    the Oral IFN-free HCV Drug Race
  7. Galapagos- Drug Discovery platform driving robust
    Partnership AbbVie, GSK, Janssen, Servier..
  8. Incyte - INCB39110 Another JAK-Fruit in INCY's
    Bucket
  9. ISIS - Beyond KYNAMRO Targeting Other Niche
    Indications
  10. Morphosys - MOR103/ MOR202 Partnering is the
    Beginning of a New Phase of Growth

5
Related Reports
  • Partnerships, Licensing, Investments and MA
    Deals and Trends for January 2014 in
    Pharmaceuticals
  • The Chinese Pharmaceuticals Market to 2024
  • Kazakhstan Pharmaceuticals and Healthcare Report
  • Estonia Pharmaceuticals and Healthcare Report
  • Canada Pharmaceuticals and Healthcare Report

6
Custom Research
  • Incase the reports dont match your requirement
    then we can do a Custom Research for you. Our
    multifarious capabilities, cross-sector expertise
    and detailed knowledge of various markets, put us
    at a unique position to take up Custom Research
    demands of yours. We provide the specifications
    of the custom research job to a dedicated team
    comprising of researchers, analysts and industry
    experts, who have close experience and
    understanding of global markets, competitive
    landscapes, various business models, market
    shares, drivers, restraints and benchmarks.

7
  • To know more Global Pharmaceutical
    Biotechnology Outlook 2014 Rising Stars

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com
Write a Comment
User Comments (0)
About PowerShow.com